Zuellig Pharma
Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to make healthcare more accessible. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region.
See below for the Latest Zuellig Pharma News, Analysis, Profit Results, Share Price Information, and Commentary.
ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
The commercialisation division of Zuellig Pharma claims the Most Differentiated Service of the Year and Outcomes-based Contracting Model of the Year titles.
Most Read
1. Exceptional medical innovations celebrated at Healthcare Asia Awards 2026 2. East Avenue Medical Center recognised for outpatient service initiative at Healthcare Asia Awards 2026 3. Singapore Cancer Center Inc. by Curie Oncology recognised at Healthcare Asia Awards 2026 4. BICOL MEDICAL CENTER triumphs at Healthcare Asia Awards 2026 5. Soeharto Heerdjan Hospital (RSSH) recognised for neuropsychiatric leadership at Healthcare Asia Awards 2026Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
The clinic integrated Western medicine, complementary therapies, and data-driven bioresonance assessments to deliver personalised preventive and regenerative care.
Commentary
Public health at scale: Lessons from implementing AI across government health programmes
Clearing the air: Why Singapore's haze problem is an eldercare crisis in plain sight
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings